市場調查報告書
商品編碼
1597058
北美素食膠囊市場預測至 2031 年 - 區域分析 - 按產品、應用、功能和最終用戶North America Vegetarian Capsules Market Forecast to 2031 - Regional Analysis - by Product, Application, Functionality, and End User |
2023年北美素食膠囊市值為5.0363億美元,預計到2031年將達到9.7633億美元;預計2023年至2031年複合年成長率為8.6%。
與明膠膠囊相比,人們對純素膠囊的偏好不斷上升,推動了北美素食膠囊市場
大多數製藥公司都採購素食膠囊而不是動物性膠囊,因為它們的水分含量低,並且對吸濕性化合物具有更好的穩定性。多年來,醫學、宗教、文化和倫理方面一直對在藥物的膠囊包衣或配方中添加動物物質存在擔憂。此外,由於相關的醫療風險,一些消費者對使用動物性藥物表示擔憂。 2023 年7 月,美國疾病管制與預防中心(CDC) 發布了一份針對Alpha-gal 症候群(AGS) 患者的報告,限制動物性藥物和補充劑的消費,因為這些藥物中75% 含有動物源性成分。此外,AGS 患者在服用含有哺乳動物成分的藥物或補充劑後表現出嚴重的過敏反應。這些情況引起了製造商生產非動物藥物和補充劑的興趣。
明膠膠囊與素食膠囊的比較分析
因素
明膠膠囊
素食膠囊
來源
牛、皮、牛和豬
植物
目標受眾
素食和非素食人口
素食主義者或素食人口
過敏
對牛和豬成分過敏
無過敏
交聯成分
與其他藥物-藥物衍生物的交聯
無交叉連結
外部成分
防腐劑
不含防腐劑
目前,市面上大量的藥物膠囊由明膠組成。然而,明膠的交聯與藥物不相容性以及對動物源明膠使用的嚴格規定鼓勵製藥商用植物成分替代明膠成分。製藥商發現,羥丙基甲基纖維素 (HPMC) 衍生的素食膠囊由於其植物來源,是明膠的良好替代品。 Vegicaps 軟膠囊是不含動物成分的膠囊的最佳例子。外殼由海藻萃取物和無麩質澱粉組成,不含改性糖和人工色素。 Vegicaps軟膠囊的優點是不含動物衍生物、易於吞嚥、柔軟、天然、更健康的產品。對於明膠膠囊,在噴塗水性腸溶聚合物分散體時,殼可能會變軟並變粘,或者可能由於乾燥過程中水分蒸發而變脆,最終失去機械穩定性。然而,在 HPMC 衍生的素食膠囊中,它對水性包衣不太敏感,並且膠囊殼堅硬,可以避免成分洩漏。
因此,對素食藥物的日益青睞有利於製造商加速素食膠囊的生產,從而推動北美素食膠囊市場的成長。
北美素食膠囊市場概況
根據美國整骨協會 (AOA) 2024 年報告中發布的資料,在美國,超過五分之四的美國成年人 (86%) 食用維生素或膳食補充劑。報告顯示,美國成年人出於個人需求或醫生、朋友或家人的建議而消費維生素或營養保健品。此外,隨著維生素缺乏症盛行率的上升,美國人口對膠囊等營養補充品的消耗量也很高。 2023 年 CRN 膳食補充劑消費者調查顯示,近 74% 的美國成年人食用膳食補充劑,其中 55% 是一般消費者。一些美國人正在轉向純素飲食。注重健康的純素食消費者在購買營養保健品和其他膳食補充品產品時會尋找「純素食商標」。
在美國,營養保健品產業提供創新的純素產品,以滿足不斷成長的消費者需求以及多樣化的消費者攝取轉向無動物成分膳食補充劑的趨勢。 2023年4月,IFF宣布推出「VERDIGEL SC」。 「VERDIGEL SC」的推出使純素軟膠囊製造商能夠提供在多個市場需求量很大的不含角叉菜膠的產品。軟膠囊在營養和補充劑領域越來越受歡迎,IFF 開發的這款新產品為製造商提供了一個合適的選擇,可以在不破壞現有生產流程、不影響性能和品質的情況下轉向基於植物的、不含角叉菜膠的替代品。
北美素食膠囊市場收入及 2031 年預測(百萬美元)
北美素食膠囊市場細分
北美素食膠囊市場按產品、應用、功能、最終用戶和國家進行分類。
根據產品,北美素食膠囊市場分為羥丙基甲基纖維素(HPMC)、普魯蘭多醣等。 2023 年,羥丙基甲基纖維素 (HPMC) 領域佔據最大的市場佔有率。
從應用來看,北美素食膠囊市場分為抗生素和抗菌藥物、維生素和膳食補充劑、抗發炎藥物、心血管治療藥物、抗酸和抗脹氣製劑等。 2023年,抗生素和抗菌藥物領域佔最大的市場。
依功能分類,北美素食膠囊市場分為速釋膠囊、緩釋膠囊和緩釋膠囊。 2023 年,速釋膠囊細分市場佔據更大的市場佔有率。
按最終用戶分類,北美素食膠囊市場分為製藥公司、營養保健品公司、合約製造組織 (CMOS) 和藥妝公司。 2023 年,製藥公司細分市場佔據最大的市場。
按國家/地區分類,北美素食膠囊市場分為美國、加拿大和墨西哥。 2023 年,美國主導北美素食膠囊市佔率。
二次元;加拿大帽; Capsugel, Inc(Lonza Group AG 的子公司);印度健康帽; Lefancaps;天然膠囊有限公司;品質;山西廣生藥用膠囊有限公司(GS膠囊);蘇尼爾醫療保健有限公司;亞辛;和浙江迴力膠囊有限公司是北美素食膠囊市場的領導公司。
The North America vegetarian capsules market was valued at US$ 503.63 million in 2023 and is expected to reach US$ 976.33 million by 2031; it is estimated to register a CAGR of 8.6% from 2023 to 2031.
Rising Preference for Vegan Capsules Over Gelatin-Based Capsules Fuels North America Vegetarian Capsules Market
The majority of pharmaceutical companies are procuring vegetarian capsules over animal-derived capsules as they have low moisture content and better stability for hygroscopic compounds. For many years, there have been medical, religious, cultural, and ethical concerns about adding animal substances to capsule coatings or formulations in pharmaceutical medicines. Also, some consumers expressed concerns over the use of animal-derived pharmaceutical medicines due to the associated healthcare risks. In July 2023, the Center for Disease Control and Prevention (CDC) published a report for Alpha-gal syndrome (AGS) patients to limit the consumption of animal-derived medicines and supplements, as 75% of these medications contain animal-sourced ingredients. Also, AGS patients revealed serious allergic reactions after consuming medications or supplements that include mammalian-derived ingredients. Such instances have raised interest among the manufacturers to produce animal-free medications and supplements.
Comparative Analysis Between Gelatin Capsules and Vegetarian Capsules
Factors
Gelatin Capsules
Vegetarian Capsules
Source
Bovine, Skin, Cow, and Pigs
Plants
Target Audience
Vegan and Nonvegetarian Population
Vegan or Vegetarian Population
Allergy
Allergy Due to Cow and Pig-Based Ingredient
No Allergies
Cross Linking Ingredients
Cross Linking with Other Drug-Drug Derivatives
No Cross Linking
External Ingredients
Preservatives
No Preservatives
Currently, the high volume of pharmaceutical capsules available in the market are composed of gelatin. However, the crosslinking of gelatin with drug incompatibilities and strict regulations on the use of animal-derived gelatin have encouraged pharmaceutical manufacturers to replace gelatin components with vegetable-based ingredients. Pharmaceutical manufacturers identified that Hydroxypropyl Methylcellulose (HPMC)-derived vegetarian capsules are a good alternative to gelatin due to its vegetable derived source. Vegicaps soft capsules are the best example of animal-free capsules. The shell is composed of seaweed extract and gluten-free starch containing no modified sugars and artificial colors. Advantages of Vegicaps soft capsules are that they are free from animal derivatives, easy to swallow, soft, natural, and healthier products. In the case of gelatin-based capsules, the shell may get soft and become sticky upon spraying aqueous enteric polymer dispersions or may become brittle due to water evaporation during drying, ultimately losing mechanical stability. However, in HPMC-derived vegetarian capsules, it is less sensitive to aqueous coating, and the capsule shell is hard that avoids leakage of the ingredients.
Therefore, rising preference toward vegetarian medicines proves advantageous for the manufacturers to accelerate the production of vegetarian capsules, which drives the North America vegetarian capsules market growth.
North America Vegetarian Capsules Market Overview
According to data published in the American Osteopathic Association (AOA) report in 2024, in the US more than 4 in 5 American adults (86%) consume vitamins or dietary supplements. The report reveals that American adults consume vitamins or nutraceuticals due to personal needs or recommendations by physicians, friends, or family members. Also, with the rising prevalence of vitamin deficiency, the consumption of nutraceutical supplements such as capsules is high among the US population. The 2023 CRN Consumer Survey on Dietary Supplements shows that almost 74% of adults in the US consume dietary supplements, among which 55% are regular consumers. Some US population is shifting toward vegan diet. Health-conscious vegan consumers look for the "Vegan Trademark" while purchasing nutraceuticals and other dietary supplement products.
In the US, the nutraceutical industry provides innovative vegan products to meet rising consumer demand and diverse consumer intake shift toward animal-free dietary supplements. In April 2023, IFF announced the launch of "VERDIGEL SC". The introduction of "VERDIGEL SC" enables manufacturers of vegan soft gels to offer carrageenan-free products that are in high demand in several markets. Softgels are gaining high popularity in the nutritional and supplement sectors, and this new product developed by the IFF offers manufacturers a suitable option to switch to plant-based, carrageenan-free alternatives without disrupting existing production processes and compromising performance and quality.
North America Vegetarian Capsules Market Revenue and Forecast to 2031 (US$ Million)
North America Vegetarian Capsules Market Segmentation
The North America vegetarian capsules market is categorized into product, application, functionality, end user, and country.
Based on product, the North America vegetarian capsules market is segmented hydroxypropyl methylcellulose (HPMC), pullulan, and others. The hydroxypropyl methylcellulose (HPMC) segment held the largest market share in 2023.
In terms of application, the North America vegetarian capsules market is categorized into antibiotic and antibacterial drug, vitamin and dietary supplement, anti-inflammatory drugs, cardiovascular therapy drugs, antacid and antiflatulent preparation, and others. The antibiotic and antibacterial drug segment held the largest market share in 2023.
By functionality, the North America vegetarian capsules market is segmented into immediate release capsules, sustained release capsules, and delayed release capsules. The immediate release capsules segment held the larger market share in 2023.
By end user, the North America vegetarian capsules market is segmented into pharmaceutical companies, nutraceutical companies, contract manufacturing organizations (CMOS), and cosmeceutical companies. The pharmaceutical companies segment held the largest market share in 2023.
By country, the North America vegetarian capsules market is segmented into the US, Canada, and Mexico. The US dominated the North America vegetarian capsules market share in 2023.
ACG; CapsCanada; Capsugel, Inc (A subsidiary of Lonza Group AG); HealthCaps India; Lefancaps; NATURAL CAPSULES LIMITED; QUALICAPS; Shanxi Guangsheng Medicinal Capsules Co (GS Capsules); Sunil Healthcare Limited; Yasin; and Zhejiang Huili Capsules Co., Ltd. are some of the leading companies operating in the North America vegetarian capsules market.